Prevalence and Impact of Neoatherosclerosis on Clinical Outcomes After Percutaneous Treatment of Second-Generation Drug-Eluting Stent Restenosis.
Zhaoyang ChenMitsuaki MatsumuraGary S MintzMasahiko NoguchiTatsuhiro FujimuraEisuke UsuiFumiyasu SeikeXun HuGe JinChenguang LiHanan SalemKhady N FallEvan ShlofmitzAjay J KirtaneJ Jane CaoJeffrey W MosesZiad A AliAllen JeremiasRichard A ShlofmitzAkiko MaeharaPublished in: Circulation. Cardiovascular interventions (2022)
Lipidic but not calcified neoatherosclerosis was associated with poor subsequent outcomes after repeat revascularization if optimal stent expansion was achieved in lesions with calcified neoatherosclerosis.